Trial Profile
Phase II study: systemic treatment with iv [intravenous] ZK219477-Epothilone [sagopilone] in recurrent glioblastoma patients
Status:
Completed
Phase of Trial:
Phase II
Latest Information Update: 18 Aug 2015
Price :
$35
*
At a glance
- Drugs Sagopilone (Primary)
- Indications Glioblastoma
- Focus Therapeutic Use
- 25 Nov 2006 New trial record.